HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE

DABRIN

Dabrin is a glucocorticosteroid. Leukocyte and muscle macrophage activity is inhibited by this drug. Dabrin limits the movement of leukocytes in the region of inflammation. This substance violates the capacity of macrophages for phagocytosis and the synthesis of interleukin-1, and it reduces its histamine release-induced capillary permeability. Moreover, this drug reduces the production of fibroblasts and collagen.

Use this medication precisely as recommended by your physician. Follow the prescription of your doctor carefully.

The medication dose your physician has given is based on your condition, other medications or food supplements you may take, and your reaction to treatment. To diminish your risks for adverse effects, don’t increase your dosage, take it regularly, or take it as instructed by your physician. Adverse events may still happen even at usual prescription dosages.

If your physician requests you to use this drug consistently, use it regularly to get the most benefits from it. To make you remember it better, take it at a fixed time every day.

Your doctor may need to modify your dosages to ease your symptoms or if you develop adverse reactions.

If you have any inquiries with regards to information, ask your physician or pharmacist.

Dabrin is used in the following conditions:

  • Osteoarthritis
  • Multiple etiologies of arthritis
  • Osteochondrosis
  • Hypothyroidism
  • Tenosynovitis
  • Bronchial asthma
  • Styloiditis
  • Ulcerative colitis
  • Scapulohumeral periarthritis
  • Autoimmune hemolytic anemia
  • Acute adrenal insufficiency
  • Hematopoiesis exhibits aplasia and hypoplasia
  • Agranulocytosis
  • Serum sickness
  • Thrombocytopenia
  • Pemphigus
  • Pyrogenic reactions
  • Malignant tumor
  • Dermatosis
  • Cerebral edema
  • Angioedema
  • Brain tumors
  • Radiation injury
  • Neurosurgical intervention
  • Meningitis
  • Encephalitis
  • Brain hemorrhage
  • Asthmatic status
  • Head injury
  • Bronchospasm
  • Shock of various origins
  • Medication-induced acute anaphylaxis reaction
  • Congenital adrenogenital syndrome
  • Acute hemolytic anemia
  • Acute eczema
  • Acute lymphoblastic leukemia
  • Acute erythroderma
  • Serious infectious diseases 
  • Agranulocytosis
  • Acute croup
  • Thrombocytopenia
  • Epicondylitis
  • Connective tissue disease
  • Bursitis
  • Acute rheumatoid arthritis
  • Compression neuropathy
  • Thyrotoxicosis-related progressive ophthalmopathy
  • Acute and subacute thyroiditis
  • Biermer’s disease

This medicine may be recommended for different uses. Approach your physician or pharmacist for more information.  

Do not use Dabrin in people with the following conditions:

  • Mold infection

Dabrin may have the following side effects:

  • Muscle weakness or limp feeling
  • Chills
  • Increased thirst or urination
  • Worsening pain
  • Constipation
  • Stiffness of a joint
  • Pancreatitis
  • Limp feeling
  • Swelling
  • Pain behind your eyes
  • Rapid weight gain
  • Shortness of breath
  • Blurred vision
  • Increased pressure within the skull or severe headaches
  • Eye pain
  • Seizure
  • Bloody or tarry stools
  • Ringing in your ears
  • Dizziness
  • Nausea
  • Tunnel vision
  • Coughing up blood
  • Leg cramps
  • Muscle weakness
  • Fluttering in your chest
  • Numbness or tingling
  • Fever
  • Tiredness

Keep in mind that your physician has recommended this drug since he or she has known that the advantage to you is more noteworthy than the risk of adverse reactions. Many individuals utilizing this medicine don’t have serious side effects. 

A serious allergy to this medication is uncommon. In any case, seek emergency medical help if you see any manifestations of a serious allergic response, including a rash, tingling or swelling particularly of the face or tongue or throat, dizziness or difficulty in breathing.

This is not a complete list of side effects. If you see other effects not recorded above, contact your physician or pharmacist.

Take extra caution in patients with the following medical conditions:

  • Pregnancy
  • Breastfeeding

Prior to taking this medicine, tell your physician or pharmacist if you are allergic to it, or if you have some other hypersensitivities. This drug may contain inert ingredients which can cause unfavorable side effects or different issues. Talk with your pharmacist for more information.

Interactions

Dabrin may interact with the following medicines:

  • Anticoagulants
  • Amphotericin B injection and potassium-depleting agents
  • Antibiotics
  • Aminoglutethimide
  • Anticholinesterases

Inform your physician about the drugs you take including over-the-counter medications, prescribed drugs, supplements, and vitamins.

This is not a complete list of drug interactions. Approach your physician or pharmacist for more details.

The effects of certain medications can change if you consume different medications or herbal products simultaneously. This can build your risk for side effects or maycause your drugs not to work effectively. These interactions are conceivable, yet don’t generally happen. Your physician or pharmacist can prevent or oversee interactions by changing how you utilize your prescriptions or by close checking.

While utilizing this drug, don’t start, stop, or change the dose of other medicines you are using without your physician’s advice. 

If an overdose is suspected, call your health care provider immediately.

Available Brands:

  • Dalalone
  • Daxafrin
  • D.dron
  • DAKSONE

Related Articles

ULTRAVIST

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultravist is used in the following conditions: Radiographic Imaging: Iopromide injection is utilized to enhance the [...]

ULTRAMOX

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultramox is used in the following conditions: Respiratory Infections: Amoxicillin is often used to treat respiratory [...]

ULTRALIV

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultraliv is used in the following conditions: Carnitine Orotate: Carnitine orotate is a combination of L-carnitine [...]